Risk Factors for Rapidly Progressive Neurological Deterioration in Cervical Spondylotic Myelopathy.
Adult
Aged
Cervical Vertebrae
/ diagnostic imaging
Comorbidity
Decompression, Surgical
/ adverse effects
Disease Progression
Female
Follow-Up Studies
Humans
Male
Middle Aged
Range of Motion, Articular
/ physiology
Retrospective Studies
Risk Factors
Spinal Cord Diseases
/ diagnostic imaging
Spondylosis
/ diagnostic imaging
Treatment Outcome
Journal
Spine
ISSN: 1528-1159
Titre abrégé: Spine (Phila Pa 1976)
Pays: United States
ID NLM: 7610646
Informations de publication
Date de publication:
15 Jun 2019
15 Jun 2019
Historique:
pubmed:
11
1
2019
medline:
31
7
2019
entrez:
11
1
2019
Statut:
ppublish
Résumé
A retrospective single-center study. This study sought to clarify the risk factors and to evaluate the surgical outcome in patients with rapidly progressive cervical spondylotic myelopathy (rp-CSM). CSM is a degenerative spine disease presenting a slow development of myelopathy. Some patients, however, show rapidly progressive neurological deterioration (especially gait disturbances) without any trauma. At present, there is little information about this condition. We studied 71 consecutive CSM patients (52 men, 19 women) with a mean age of 67.1 years, and the follow-up period was 1 year. Patients were divided into two groups: rp-CSM and chronic-CSM (c-CSM) groups. The Japanese Orthopaedic Association score and various clinical differences, including age, sex, comorbidity, the waiting period from symptomatic onset to surgery, cervical range of motion, and intramedullary MR T2-hyperintensity were analyzed, and independent risk factors were determined using a logistic regression analysis. Eighteen of 71 patients (25.4%) were diagnosed with rp-CSM. There were no significant differences between the two groups with regard to age, sex, or cervical range of motion. In the rp-CSM group, the preoperative upper/lower extremities and bladder functions were worse, and the waiting period for surgery was shorter (rp-CSM 1.2 mo, c-CSM 25.7 mo). Patients with rp-CSM had a history of cardiovascular event (CVE) (rp-CSM 44.4%, c-CSM 15.1%) and presented with MR T2-hyperintensity (rp-CSM 94.4%, c-CSM 58.5%), especially at the C4/5 disc level. Independent risk factors were a history of CVE (odds ratio = 4.7) and MR T2-hyperintensity (odds ratio = 12.5). The rp-CSM group showed a better neurological recovery after decompression surgery (the Japanese Orthopaedic Association recovery rate: rp-CSM 64.5%, c-CSM 40.7%). A history of CVE and MR T2-hyperintensity were risk factors for rp-CSM. Despite rapid neurological deterioration, rp-CSM patients showed a good neurological recovery after surgery, and thus indicating that rp-CSM is a reversible condition. 4.
Sections du résumé
STUDY DESIGN
METHODS
A retrospective single-center study.
OBJECTIVE
OBJECTIVE
This study sought to clarify the risk factors and to evaluate the surgical outcome in patients with rapidly progressive cervical spondylotic myelopathy (rp-CSM).
SUMMARY OF BACKGROUND DATA
BACKGROUND
CSM is a degenerative spine disease presenting a slow development of myelopathy. Some patients, however, show rapidly progressive neurological deterioration (especially gait disturbances) without any trauma. At present, there is little information about this condition.
METHODS
METHODS
We studied 71 consecutive CSM patients (52 men, 19 women) with a mean age of 67.1 years, and the follow-up period was 1 year. Patients were divided into two groups: rp-CSM and chronic-CSM (c-CSM) groups. The Japanese Orthopaedic Association score and various clinical differences, including age, sex, comorbidity, the waiting period from symptomatic onset to surgery, cervical range of motion, and intramedullary MR T2-hyperintensity were analyzed, and independent risk factors were determined using a logistic regression analysis.
RESULTS
RESULTS
Eighteen of 71 patients (25.4%) were diagnosed with rp-CSM. There were no significant differences between the two groups with regard to age, sex, or cervical range of motion. In the rp-CSM group, the preoperative upper/lower extremities and bladder functions were worse, and the waiting period for surgery was shorter (rp-CSM 1.2 mo, c-CSM 25.7 mo). Patients with rp-CSM had a history of cardiovascular event (CVE) (rp-CSM 44.4%, c-CSM 15.1%) and presented with MR T2-hyperintensity (rp-CSM 94.4%, c-CSM 58.5%), especially at the C4/5 disc level. Independent risk factors were a history of CVE (odds ratio = 4.7) and MR T2-hyperintensity (odds ratio = 12.5). The rp-CSM group showed a better neurological recovery after decompression surgery (the Japanese Orthopaedic Association recovery rate: rp-CSM 64.5%, c-CSM 40.7%).
CONCLUSION
CONCLUSIONS
A history of CVE and MR T2-hyperintensity were risk factors for rp-CSM. Despite rapid neurological deterioration, rp-CSM patients showed a good neurological recovery after surgery, and thus indicating that rp-CSM is a reversible condition.
LEVEL OF EVIDENCE
METHODS
4.
Identifiants
pubmed: 30628980
doi: 10.1097/BRS.0000000000002969
pii: 00007632-201906150-00008
doi:
Types de publication
Case Reports
Journal Article
Langues
eng
Pagination
E723-E730Références
Oshima Y, Seichi A, Takeshita K, et al. Natural course and prognostic factors in patients with mild cervical spondylotic myelopathy with increased signal intensity on T2-weighted magnetic resonance imaging. Spine (Phila Pa 1976) 2012; 37:1909–1913.
Baptiste DC, Fehlings MG. Pathophysiology of cervical myelopathy. Spine J 2006; 6:S190–S197.
Hamamoto Y, Ogata T, Morino T, et al. Real-time direct measurement of spinal cord blood flow at the site of compression: relationship between blood flow recovery and motor deficiency in spinal cord injury. Spine (Phila Pa 1976) 2007; 32:1955–1962.
Kurokawa R, Murata H, Ogino M, et al. Altered blood flow distribution in the rat spinal cord under chronic compression. Spine (Phila Pa 1976) 2011; 36:1006–1009.
Kubota K, Saiwai H, Kumamaru H, et al. Neurological recovery is impaired by concurrent but not by asymptomatic pre-existing spinal cord compression after traumatic spinal cord injury. Spine (Phila Pa 1976) 2012; 37:1448–1455.
Morishita Y, Matsushita A, Maeda T, et al. Rapid progressive clinical deterioration of cervical spondylotic myelopathy. Spinal Cord 2015; 53:408–412.
Yonenobu K, Abumi K, Nagata K, et al. Interobserver and intraobserver reliability of the Japanese Orthopaedic Association scoring system for evaluation of cervical compression myelopathy. Spine (Phila Pa 1976) 2001; 26:1890–1894.
Vitzthum HE, Dalitz K. Analysis of five specific scores for cervical spondylogenic myelopathy. Eur Spine J 2007; 16:2096–2103.
Ara T, Iizuka H, Sorimachi Y, et al. Evaluation of neck pain by using a visual analog scale before and after laminoplasty in patients with cervical myelopathy: relationship with clinical results. J Neurosurg Spine 2010; 12:635–640.
Iizuka H, Shimizu T, Tateno K, et al. Extensor musculature of the cervical spine after laminoplasty: morphologic evaluation by coronal view of the magnetic resonance image. Spine (Phila Pa 1976) 2001; 26:2220–2226.
Iizuka H, Nakajima T, Iizuka Y, et al. Preservation of the insertion of the deep extensor musculature to the C-2 spinous process prevented significant changes in cervical alignment after laminoplasty. J Neurosurg Spine 2007; 7:610–614.
Kanda Y. Investigation of the freely available easy-to-use software ’EZR’ for medical statistics. Bone Marrow Transplant 2013; 48:452–458.
White AA III, Johnson RM, Panjabi MM, et al. Biomechanical analysis of clinical stability in the cervical spine. Clin Orthop Relat Res 1975; 109:85–96.
Tachibana T, Maruo K, Arizumi F, et al. Predictive factors for acute exacerbation of cervical compression myelopathy. J Clin Neurosci 2018; 48:160–162.
Chikuda H, Seichi A, Takeshita K, et al. Correlation between pyramidal signs and the severity of cervical myelopathy. Eur Spine J 2010; 19:1684–1689.
Nouri A, Tetreault L, Zamorano JJ, et al. Role of magnetic resonance imaging in predicting surgical outcome in patients with cervical spondylotic myelopathy. Spine (Phila Pa 1976) 2015; 40:171–178.
Nouri A, Tetreault L, Zamorano JJ, et al. The relationship between MRI signal intensity changes, clinical presentation, and surgical outcome in degenerative cervical myelopathy: analysis of a global cohort. Spine (Phila Pa 1976) 2015; 40:171–178.
Dokai T, Nagashima H, Nanjo Y, et al. Surgical outcomes and prognostic factors of cervical spondylotic myelopathy in diabetic patients. Arch Orthop Trauma Surg 2012; 132:577–582.
Karadimas SK, Erwin WM, Ely CG, et al. Pathophysiology and natural history of cervical spondylotic myelopathy. Spine (Phila Pa 1976) 2013; 38 (22 suppl 1):S21–S36.
Benjamin EJ, Blaha MJ, Chiuve SE, et al. Heart Disease and Stroke Statistics-2017 update: a report from the American Heart Association. Circulation 2017; 135:e146–e603.
Bednarik J, Kadanka Z, Dusek L, et al. Presymptomatic spondylotic cervical myelopathy: an updated predictive model. Eur Spine J 2008; 17:421–431.
Yue WM, Tan SB, Tan MH, et al. The Torg-Pavlov ratio in cervical spondylotic myelopathy: a comparative study between patients with cervical spondylotic myelopathy and a non-spondylotic, non-myelopathic population. Spine (Phila Pa 1976) 2001; 26:1760–1764.
Fehlings MG, Tator CH, Linden RD. The effect of nimodipine and dextran on axonal function and blood flow following experimental spinal cord injury. J Neurosurg 1989; 71:403–416.
Shields CB, Zhang YP, Shields LB, et al. The therapeutic window for spinal cord decompression in a rat spinal cord injury model. J Neurosurg Spine 2005; 3:302–307.
Vidal PM, Karadimas SK, Ulndreaj A, et al. Delayed decompression exacerbates ischemia-reperfusion injury in cervical compressive myelopathy. JCI Insight 2017; 2:e92512.
Karadimas SK, Moon ES, Yu WR, et al. A novel experimental model of cervical spondylotic myelopathy (CSM) to facilitate translational research. Neurobiol Dis 2013; 54:43–58.
Ohya J, Chikuda H, Oichi T, et al. Perioperative stroke in patients undergoing elective spinal surgery: a retrospective analysis using the Japanese diagnosis procedure combination database. BMC Musculoskelet Disord 2015; 16:276.